NasdaqGM:RYTMBiotechs
Assessing Rhythm Pharmaceuticals (RYTM) Valuation After Recent Share Price Weakness
Recent share performance and business context
With no single headline event driving Rhythm Pharmaceuticals (RYTM) today, the stock’s recent moves and fundamentals are in focus as investors weigh share price performance against the company’s rare disease portfolio.
See our latest analysis for Rhythm Pharmaceuticals.
The recent 1 day share price return of a 2.45% decline and 90 day share price return of a 19.9% decline contrast with a 1 year total shareholder return of 28.71% and a very large 3...